Cancer Care in the National Cancer Institute Center for Cancer Research

This study is currently recruiting participants.
Verified February 2014 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00923065
First received: June 17, 2009
Last updated: March 25, 2014
Last verified: February 2014
  Purpose

This study provides cancer care through the National Cancer Institute's Medical Oncology Branch (MOB) to patients who are not enrolled in an active treatment research protocol. Patients receive standard treatments only; no investigational therapies are provided on this protocol.

Patients 18 years of age and older may be eligible for this protocol. Candidates are patients for whom an NCI investigator decides that the interests of the patient and the NCI are best served by the patient's enrollment in this protocol to receive care and follow-up within the MOB. This includes patients in the following categories:

  • Patients previously enrolled in NCI trials whose participation in this protocol may continue to provide researchers important scientific information
  • Patients who will be eligible for a research protocol within the foreseeable future
  • Patients whose medical welfare will be seriously compromised by referral back to the community, such as patients with a rare or complex disease for which community resources are inadequate or unavailable
  • Terminally ill patients who have received most of their specialized medical care at the Clinical Center and for whom humanitarian considerations dictate that they continue to receive their medical care at NIH after going off study for the remaining weeks or months of life
  • Patients with cancer or HIV, or people at risk for cancer or HIV for whom cancer treatments at the NCI are requested through the MOB consult service
  • Patients who are participating in a non-treatment NCI research protocol and require standard-of-care therapy
  • Patients with cancer or HIV or people at risk for cancer for whom cancer treatment or management at the NCI would add significant value to the institute's cancer training program

Participants receive standard medical care, including periodic routine laboratory tests, diagnostic x-rays, and nuclear medicine scans to monitor the course of illness and the effects of any treatment.


Condition
Oncology

Study Type: Observational
Official Title: Care of Adult Oncology Patient, CCR, NCI

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 5000
Study Start Date: April 2004
Detailed Description:

Background:

It may be in the interest of the Center for Cancer Research (CCR) to treat and/or follow certain subjects who are not currently enrolled on an active research protocol.

Objective:

The objective of this protocol is to add value to the medical or surgical oncology training programs by providing treatment and medical follow-up for NCI patients and other Institute consult patients not currently enrolled on an active research protocol.

Eligibility:

It is in the best interests of the subject and the CCR for the subject to receive treatment at the NCI, NIH Intramural Research Program.

Design:

No investigational therapies will be administered on this study. This protocol is not a platform to perform pilot studies of off-label uses for standard agents.

This protocol will provide the administrative vehicle to provide cancer care for patients in the intramural research program.

Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for subjects who are not currently enrolled on an active protocol.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patient must be age 18 or older.

A CCR investigator decides that it is in the best interest of the patient and the CCR for the subject to receive treatment and follow-up at the NCI/NIH.

The patient is able and willing to provide informed consent.

EXCLUSION CRITERIA:

Subjects who are receiving an investigational therapy.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00923065

Contacts
Contact: William L Dahut, M.D. (301) 435-8183 dahutw@mail.nih.gov

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937      
Sponsors and Collaborators
Investigators
Principal Investigator: William L Dahut, M.D. National Cancer Institute (NCI)
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00923065     History of Changes
Obsolete Identifiers: NCT00898625
Other Study ID Numbers: 040165, 04-C-0165
Study First Received: June 17, 2009
Last Updated: March 25, 2014
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Standard Care
Oncology

ClinicalTrials.gov processed this record on April 17, 2014